1. Home
  2. ATXG vs CANF Comparison

ATXG vs CANF Comparison

Compare ATXG & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATXG

Addentax Group Corp.

N/A

Current Price

$4.80

Market Cap

4.1M

ML Signal

N/A

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

N/A

Current Price

$3.01

Market Cap

4.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATXG
CANF
Founded
2014
1994
Country
China
Israel
Employees
112
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
4.7M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
ATXG
CANF
Price
$4.80
$3.01
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$50.00
AVG Volume (30 Days)
69.2K
914.9K
Earning Date
02-13-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$2,715,455.50
Revenue Next Year
N/A
$101.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.17
52 Week High
$7.94
$10.40

Technical Indicators

Market Signals
Indicator
ATXG
CANF
Relative Strength Index (RSI) 51.31 45.14
Support Level $4.79 $2.91
Resistance Level $7.92 $3.24
Average True Range (ATR) 1.02 0.23
MACD -0.34 0.05
Stochastic Oscillator 9.41 14.40

Price Performance

Historical Comparison
ATXG
CANF

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: